# FARXIGA

NDC: 70518-4614
Generic name: DAPAGLIFLOZIN
Labeler / Manufacturer: REMEDYREPACK INC.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260423

FDA application: NDA202293

## Active ingredients

- DAPAGLIFLOZIN PROPANEDIOL: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70518-4614"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70518-4614
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ef9e9c8c-5460-4193-952a-0c249dd071bd